FXN and Friedreich ataxia: Recent studies have demonstrated that the levels of FXN protein are significantly reduced in these animals (Gérard et al., 2023; Kalef-Ezra et al., 2023) and that this animal model best reflects the course of disease observed in FRDA patients.